Clinical Trials Browser

Localized Muscle Invasive Bladder Urothelial Carcinoma × sacituzumab govitecan × 1 year × Clear all

NCT05833867 2026-03-13

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Phase 1 Recruiting

Localized Muscle Invasive Bladder Urothelial Carcinoma